PTC THERAPEUTICS, INC. (PTCT) Earnings
PTC THERAPEUTICS, INC.'s most recently reported earnings, recent earnings filings (8-K) and headline annual financials, sourced from SEC EDGAR.
Last reported earnings
Oct 29, 2026
From the latest earnings 8-K
Revenue • FY2025
$1.73B
▲ 114.5%YoY
Diluted EPS • FY2025
$7.78
▲ 264.5%YoY
Reported earnings dates are based on the latest 8-K (Item 2.02) filings. The next earnings date is an estimate projected from PTCT's historical reporting pattern, not a company-confirmed date.
Headline financials
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $1.73B | $682.64M | — | $7.78 | $702.34M | 50.1% | +114.5% |
| FY2024 | $806.78M | -$363.3M | — | -$4.73 | -$114.19M | -37.5% | -14.0% |
| FY2023 | $937.82M | -$626.6M | — | -$8.37 | -$186.86M | -46.9% | +34.2% |
| FY2022 | $698.8M | -$559.02M | — | -$7.79 | -$388.67M | -64.0% | +29.8% |
Recent earnings filings
| Filed | Form | Accession |
|---|---|---|
| Oct 29, 2026 | 8-K (2.02) | 0001104659-26-120200EDGAR |
| Jul 30, 2026 | 8-K (2.02) | 0001070081-26-000016EDGAR |
| May 7, 2026 | 8-K (2.02) | 0001070081-26-000011EDGAR |
| Feb 19, 2026 | 8-K (2.02) | 0001104659-26-017546EDGAR |
| Jan 12, 2026 | 8-K (2.02) | 0001104659-26-002799EDGAR |
| Nov 4, 2025 | 8-K (2.02) | 0001070081-25-000026EDGAR |
| Aug 7, 2025 | 8-K (2.02) | 0001558370-25-010770EDGAR |
| May 6, 2025 | 8-K (2.02) | 0001070081-25-000018EDGAR |
Never miss a PTCT filing.
Get an email when PTCT files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Nov 9, 2026Source: SEC EDGAR.